Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 6180810, 13 pages
https://doi.org/10.1155/2018/6180810
Review Article

Use of Jianpi Jiedu Herbs in Patients with Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis

1Department of Integrated Chinese and Western Medicine, The Second Hospital of Xiangya, Central South University, Changsha 410008, China
2Department of Cardiology, Affiliated Bao’an TCM Hospital, Guangzhou University of Traditional Chinese Medicine, Shenzhen, Guangdong, China

Correspondence should be addressed to Sifang Zhang; nc.ude.usc@5002gnahzgnafis

Received 3 May 2017; Revised 16 December 2017; Accepted 26 December 2017; Published 29 January 2018

Academic Editor: Andrea Maxia

Copyright © 2018 Shaofan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Dai, R. S. Zheng, and X. N. Zou, “Analysis and prediction of colorectal cancer incidence trend in China,” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 46, no. 7, pp. 598–603, 2012. View at Google Scholar
  2. I. Soerjomataram, J. Lortet-Tieulent, D. M. Parkin et al., “Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions,” The Lancet, vol. 380, no. 9856, pp. 1840–1850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. International Agency for Research on Cancer (IARC), “Colorectal Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012,” 2012.
  4. I. Leake, “Colorectal cancer: Understanding the routes of metastasis in colorectal cancer,” Nature Reviews Gastroenterology & Hepatology, vol. 11, no. 5, p. 270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Hubbard and A. Grothey, “Colorectal cancer in 2014: Progress in defining first-line and maintenance therapies,” Nature Reviews Clinical Oncology, vol. 12, no. 2, pp. 73-74, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Docherty, J. R. McGregor, P. J. O'Dwyer, and D. J. Galloway, “Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy,” British Journal of Surgery, vol. 81, no. 7, pp. 1082–1082, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Tian, C. Chen, F. Yang et al., “Establishment of apoptotic regulatory network for genetic markers of colorectal cancer and optimal selection of traditional Chinese medicine target,” Saudi Journal of Biological Sciences, vol. 24, no. 3, pp. 634–643, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Y. Shi and Z. F. Xu, “Research progression of chemotherapy to colorectal cancer,” Chinese Journal of Cancer Prevention and Treatment, vol. 19, pp. 1915–1918, 2012. View at Google Scholar
  9. C. Tournigand, T. André, E. Achille et al., “FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study,” Journal of Clinical Oncology, vol. 22, no. 2, pp. 229–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Chan, O. L. Griffith, I. T. Tai, and S. J. M. Jones, “Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers,” Cancer Epidemiology, Biomarkers & Prevention, vol. 17, no. 3, pp. 543–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. O'Connell, M. A. Maggard, and C. Y. Ko, “Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging,” Journal of the National Cancer Institute, vol. 96, no. 19, pp. 1420–1425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. L. L. Yin and C. Y. Jiang, “Observation on the influence of Shenqi-Fuzheng injection on T-lymphocyte subsets, NK cell and the leukocyte of the patients with advanced gastric cancer,” International Journal of Traditional Chinese Medicine, vol. 3, no. 2, pp. 22–24, 2013. View at Google Scholar
  13. X. L. Li and J. Ma, “Clinical research progress of combined traditional Chinese and western medicine treatment in treating colorectal cancer,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 22, no. 03, pp. 323–325, 2013. View at Google Scholar
  14. W. F. Qin and J. Q. He, “Clinical observation of Yiqi Huoxue decotion combined with chemotherapy treating postoperative colorectal cancer patients,” Liaoning Journal of Traditional Chinese Medicine, vol. 38, no. 02, pp. 290-291, 2011. View at Google Scholar
  15. S. Deng, B. Hu, and H. An, “Traditional chinese medicinal syndromes and treatment in colorectal cancer,” Journal of Cancer Therapy, vol. 03, no. 06, pp. 888–897, 2012. View at Publisher · View at Google Scholar
  16. X. N. Wang and J. G. Huo, “Explore the thought and method of traditional Chinese medicine treating colorectal cancer,” Journal of Basic Chinese Medicine, vol. 13, no. 09, pp. 681-682, 2007. View at Google Scholar
  17. J. F. Ding, Y. S. Huang, and M. H. Li, “Professor Shi Zhiming's clinical experience in treating carcinoma of large intestine,” Shanghai Journal of Traditional Chinese Medicine, vol. 41, no. 05, pp. 43-44, 2007. View at Google Scholar
  18. Chinese Anti-Cancer Association, New Standard of Diagnosis and Treatment of Common Malignant Tumors, Beijing Union Medical University Press, Beijing, China, 1999.
  19. X. Y. Zheng, Clinical Guideline of New Drugs for Traditional Chinese Medicine, Medicine Science and Technology Press of China, Beijing, China, 2002.
  20. Internal Medicine of Traditional Chinese Medicine", Planned Textbook for TCM Colleges and Universities in New Century, 2007.
  21. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, The Cochrane Collaboration, 5.0.2 edition, 2010.
  22. A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: Is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Moher, B. Pham, A. Jones et al., “Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?” The Lancet, vol. 352, no. 9128, pp. 609–613, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Lai, “Clinical research on method of strengthening spleen and replenishing Qi and detoxicating and removing blood stasis combined with FOLFOX4 chemotherapy treating advanced colorectal carcinoma,” Liaoning Journal of Traditional Chinese Medicine, vol. 39, no. 5, pp. 849–851, 2012. View at Google Scholar
  25. M. Y. Fan, The Clinical Study of JianPiBuShenHuaShiJieDu Decotion With L-OHP+S-1 Chemotherapy in the Treatment of Patients With advanced Colorectal Tumor, Nanjing University of Chinese Medicine, 2013.
  26. R. J. Zhao, Clinical research of Tonifying Spleen and Kidney and Dispelling Stasis Detoxification Decoction combined with FOLFIRI chemotherapy in the treatment of advanced colon cancer, Nanjing University of Chinese Medicine, 2015.
  27. Z. Y. Zhang, Clinical study of JianPiHuaShiJieDu Decotion with chemotherapy in the treatment of patients with advanced colorectal tumor, Nanjing University of Chinese Medicine, 2009.
  28. D. Yuan, Theoretical and Clinical Research on Spleen-Tonifying, Dampness-Resolving, Stasis and Toxin-Removing in the Treatment of Advanced Colorectal Carcinoma, Nanjing University of Chinese Medicine, 2010.
  29. L. Zhu, Spleen the Dampness Quyu Detoxification Prescription Combined with FOLFIRI Regimen for Treatment of Advanced Colorectal Cancer, Nanjing University of Chinese Medicine, 2012.
  30. W. W. Zhang, J. Chen, and G. Q. Xie, “Clinical study of JianPiJieDu decotion combined with capecitabine in the treatment of patients with advanced colorectal tumor,” Journal of Shandong University of Traditional Chinese Medicine, vol. 25, no. 04, pp. 31–34, 2013. View at Google Scholar
  31. Y. Zhang, J. H. Xu, and Y. Sun, “Clinical study of Jianpijiedu-Decoction plus FOLFOX4 regimen in the treatment of advanced colorectal cancer,” Global Traditional Chinese Medicine, vol. 3, no. 2, pp. 117–120, 2010. View at Google Scholar
  32. Y. B. Zhang, X. Liu, and Q. Ji, “Clinical research on treating metastatic colorectal cancer with Jianpi Jiedu decoction and chemotherapy,” Journal of Chinese Medicine, vol. 30, no. 06, pp. 2090–2093, 2015. View at Google Scholar
  33. P. Y. Li, Clinical studies on impact of quality of life of Jianpi Jiedu Huayu therapy in the treatment of patients with advanced colorectal cancer, Nanjing University of Chinese Medicine, 2010.
  34. F. Y. Zhu, B. Wang, and Y. Ai, “Clinical study of JianPiYiQiJieDu Decotion with chemotherapy in the treatment of patients with advanced colorectal tumor,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 25, no. 03, pp. 261–263, 2016. View at Google Scholar
  35. C. Yao and H. C. Ren, “Clinical observation of 21 cases advanced colorectal cancer patients with combined traditional Chinese and western medicine treatment,” Journal of New Chinese Medicine, vol. 46, no. 12, pp. 161–163, 2014. View at Google Scholar
  36. C. Taylor, A. J. Munro, R. Glynne-Jones et al., “Multidisciplinary team working in cancer: what is the evidence?” BMJ, vol. 340, c951 pages, 2010. View at Publisher · View at Google Scholar
  37. M. McCulloch, C. See, X. Shu et al., “Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials,” Journal of Clinical Oncology, vol. 24, no. 3, pp. 419–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. R. Liu, H. Y. Liu, R. C. Wang et al., “Clinical study of Chinese medicine attenuated synergistic effect on colorectal cancer after operation,” Journal of Hebei Traditional Chinese Medicine and Pharmacology, vol. 28, pp. 12-13, 2013. View at Google Scholar
  39. J. Y. Douillard, D. Cunningham, A. D. Roth et al., “Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial,” The Lancet, vol. 355, no. 9209, pp. 1041–1047, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. A. De Gramont, A. Figer, M. Seymour et al., “Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 2938–2947, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. W. B. Chen and G. J. Zhu, “Safety observation of FOLFOX regimen in the treatment of advanced colorectal cancer,” Modern Medical, vol. 18, pp. 92-93, 2012. View at Google Scholar
  42. X. J. Jin, H. Wang, and W. D. Li, “Observation of 33 cases advanced colorectal cancer with FOLFOX6 regimen,” Guide China Medical, pp. 143-144, 2013. View at Google Scholar
  43. J. H. Zhao, J. L. Wei, and T. J. Zhang, “Effect of Shengyu Decoction on spleen index and tissue pathology of bone marrow depression mice,” Journal of Emergency in Traditional Chinese Medicine, vol. 6, pp. 928–930, 2013. View at Google Scholar
  44. J. H. Mao, Z. L. Lv, and Q. L. Zeng, “Effects of the polysaccharide of Atractylis macrocephala Koidz on the function of mouse T lymphocyte,” Immunological Journal, vol. 12, no. 4, 1996. View at Google Scholar
  45. X. H. Tang, “The influence of macrocephala polysaccharide of atractylodes on the immune function of mice,” Traditional Chinese Medicinal Research, vol. 11, 1998. View at Google Scholar
  46. A. Tseng, C.-H. Yang, C.-H. Chen et al., “An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract,” Oncology Reports, vol. 35, no. 2, pp. 659–668, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. P.-H. Lu, M.-B. Chen, C. Ji, W.-T. Li, M.-X. Wei, and M.-H. Wu, “Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings,” Oncotarget , vol. 7, no. 29, pp. 45889–45900, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. B. J. Kim, S. Lee, J. H. Shim, H. Gim, and H. S. Park, “Ethanol extract of oldenlandia diffusa–an effective chemotherapeutic for the treatment of colorectal cancer in humans,” Journal of Pharmacopuncture, vol. 19, no. 1, pp. 51–58, 2016. View at Publisher · View at Google Scholar
  49. J. H. Wang, S. R. Li et al., “Ten years review of screening and early diagnosis of colorectal cancer in China: 1994–2005,” Gastroenterology, vol. 11, pp. 245–250, 2006. View at Google Scholar
  50. W. B. Chen and G. J. Zhu, “Efficacy and safety of FOLFOX regimen in the treatment of advanced stage colorectal cancer,” Modern Medical (China), vol. 18, pp. 92-93, 2012. View at Google Scholar